US FDA approves Tonix Pharma’s drug to manage pain related to chronic condition
The U.S. Food and Drug Administration has approved Tonix Pharmaceuticals’ (TNXP.O) drug to manage pain related to a type of chronic condition called fibromyalgia, the company said on Friday.
The approval paves the way for the drug to be the first new treatment option in over 15 years for patients with fibromyalgia, which causes widespread pain, fatigue as well as problems with sleep and memory.
Patients have so far relied on older drugs such as Lyrica, Cymbalta and AbbVie’s (ABBV.N) Savella.
